Human chorionic gonadotropin modulates prostate cancer cell survival after irradiation or HMG CoA reductase inhibitor treatment.

Yacoub A, Hawkins W, Hanna D, Young H, Park MA, Grant M, Roberts JD, Curiel DT, Fisher PB, Valerie K, Grant S, Hagan MP, Dent P

Open source

DOI: 10.1124/mol.106.031153
Published: 2007 Jan
Container: Molecular pharmacology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 37/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
cautionRetraction Watch correction: 1 correction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1124/mol.106.031153,
  title = {Human chorionic gonadotropin modulates prostate cancer cell survival after irradiation or HMG CoA reductase inhibitor treatment.},
  author = {Yacoub A and Hawkins W and Hanna D and Young H and Park MA and Grant M and Roberts JD and Curiel DT and Fisher PB and Valerie K and Grant S and Hagan MP and Dent P},
  year = {2007},
  journal = {Molecular pharmacology},
  doi = {10.1124/mol.106.031153},
  url = {https://doi.org/10.1124/mol.106.031153}
}

RIS

TY  - JOUR
TI  - Human chorionic gonadotropin modulates prostate cancer cell survival after irradiation or HMG CoA reductase inhibitor treatment.
AU  - Yacoub A
AU  - Hawkins W
AU  - Hanna D
AU  - Young H
AU  - Park MA
AU  - Grant M
AU  - Roberts JD
AU  - Curiel DT
AU  - Fisher PB
AU  - Valerie K
AU  - Grant S
AU  - Hagan MP
AU  - Dent P
PY  - 2007
JO  - Molecular pharmacology
DO  - 10.1124/mol.106.031153
UR  - https://doi.org/10.1124/mol.106.031153
ER  -

APA

A, Y., W, H., D, H., H, Y., MA, P., M, G., JD, R., DT, C., PB, F., K, V., S, G., MP, H., & P, D. (2007). Human chorionic gonadotropin modulates prostate cancer cell survival after irradiation or HMG CoA reductase inhibitor treatment.. Molecular pharmacology. https://doi.org/10.1124/mol.106.031153

Source records

pubmed · retrieved 2026-09-25T18:59:17.699Z